Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Panel Loosens Avandia Safety Restrictions
Despite some concern over whether the diabetes drug Avandia can increase heart problems, an FDA panel Thursday loosened restrictions on how doctors can prescribe the drug.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
